TD Cowen analyst Phil Nadeau maintained a Buy rating on Syndax Pharmaceuticals (SNDX – Research Report) today. The company’s shares closed last ...
Following US approval in May this year, South Korea’s Samsung Bioepis and US biotech Biogen have now won approval from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback